Using Twitter for the identification of COVID-19 vaccine-associated haematological adverse events
Lancet Haematol
.
2022 Jan;9(1):e12-e13.
doi: 10.1016/S2352-3026(21)00378-1.
Authors
Charles L Bennett
1
,
Krishna Gundabolu
2
,
Larry W Kwak
3
,
Benjamin Djulbegovic
3
,
Oscar Champigneulle
3
,
Brian Josephson
4
,
Linda Martin
4
,
Steven T Rosen
3
Affiliations
1
The City of Hope Comprehensive Cancer Center, Duarte, CA, USA. Electronic address: bennettc@cop.sc.edu.
2
The University of Nebraska - Omaha School of Medicine, Omaha, NE, USA.
3
The City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
4
The University of South Carolina College of Pharmacy, Columbia, SC, USA.
PMID:
34971576
PMCID:
PMC8714180
DOI:
10.1016/S2352-3026(21)00378-1
No abstract available
MeSH terms
COVID-19 Vaccines
COVID-19*
Humans
SARS-CoV-2
Social Media*
Substances
COVID-19 Vaccines
Grants and funding
R01 CA102713/CA/NCI NIH HHS/United States